National meeting about advanced molecular cancer diagnostics
Tuesday the 11th of June oncologist and pathologist from all the University Hospitals in Norway gathered at the Radiumhospital to discuss implementation of personalized medicine in cancer treatment.
The meeting was organized by the Division of Cancer Medicine at OUS to highlight the needs and challenges related to the advanced molecular diagnostics needed for implementation of personalized medicine in both clinic practice and clinical trials.
Published in Level 2 journals, first or last author from Oslo University Hospital.
Zeller B, Arad-Cohen N, Cheuk D, De Moerloose B, Navarro JMF, Hasle H, Jahnukainen K, Juul-Dam KL, Kaspers G, Kovalova Z, Jonsson OG, Lausen B, Munthe-Kaas M, Nystrom UN, Palle J, Pasauliene R, Pronk CJ, Saks K, Tierens A, Abrahamsson J(2024) Management of hyperleukocytosis in pediatric acute myeloid leukemia using immediate chemotherapy without leukapheresis: results from the NOPHO-DBH AML 2012 Protocol Haematologica(in press) DOI 10.3324/haematol.2024.285285, PubMed 38721737
Halvorsen B, Viermyr HK, Ueland T, Sagen EL, Michelsen AE, Bjerkeli V, Nor-Solidarity Study Group, Tveita AA, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Trøseid M, Dahl TB, Aukrust P, Gregersen I(2024) IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement J Infect, 106176(in press) DOI 10.1016/j.jinf.2024.106176, PubMed 38719108
Alehagen U, Alexander J, Aaseth JO, Larsson A, Opstad TB(2024) Supplementation with selenium and coenzyme Q10 in an elderly Swedish population low in selenium - positive effects on thyroid hormones, cardiovascular mortality, and quality of life BMC Med, 22(1), 191 DOI 10.1186/s12916-024-03411-1, PubMed 38714999